GL Capital Group

Climate Impact & Sustainability Data (2023)

Implemented energy-saving policy and actions (75%)
Assessed scope 1 and scope 2 GHG emissions data management capacity (100%)
Implemented reclaimed water recycling in Shennong Herbal Garden, saving water of 0.95 million m³ per year (Baiyunshan)
Zhe Jiang Peptites Biotech set carbon peaking and carbon neutrality goals
Jin Kang Pu Nutrition installed rooftop solar panels at the production site in Zhejiang Province (3,501 m3)

Zero turnover rate with no employee leaving in 2023
Employee satisfaction index of 85.35% (Jin Kang Pu Nutrition)
95% participant ratio for 2023 trainings
25 partners are female
~50% of new portfolio companies were assessed ESG performance
100% of the new portfolio companies were included in ESG grievance monitoring
100% companies monitored for ESG incident of Fund IV
100% companies were included in ESG data monitoring program
ESG incident involved 0 grievance cases received
Conducted 114 public service events and 975 community events, and donated approximately 3 million RMB in public service (Baiyunshan)
Donation of 500,000 RMB (Challenge Animal Health)
Donation of 106,538.6 RMB (Jin Kang Pu Nutrition)
Participated in community charity activities to care for patients’ health (SciClone Pharmaceuticals)
Published 13 articles on the application of its products and wound care (Foryou Medical)

Implemented health and safety policy and procedure (100%)
Implemented product quality assurance and recalls policy and procedure (100%)
Implemented anti-corruption, anti-bribery and fraud prevention policy and procedure (100%)
Implemented customer privacy protection policy and procedure (100%)
Offered anti-corruption trainings for employees and the management (100%)
Zhe Jiang Peptites Biotech joined the UNGC and developed a comprehensive business ethics management system
Zero business ethics breaches in 2023

Long-term Goals:

Achieve carbon neutrality of operational emissions from 2045 (Scope 1 and Scope 2) (Zhe Jiang Peptites Biotech)
Achieve net-zero emissions by 2050 (Scope 1, Scope 2 and Scope 3) (Zhe Jiang Peptites Biotech)

Medium-term Goals:

Short-term Goals:

Enhance ESG integration over investment cycle
Explore opportunities to develop customized ESG value-creation plans for pilot portfolios

Evolving sustainability regulatory landscape and rising expectations regarding sustainability performance for both GL Capital and its portfolio companies.

Proactive integration of sustainability practices
Conducting ESG assessments for all targets of USD Fund III and newly established USD Fund IV
Expanding and enhancing ESG value creation, monitoring, and engagement initiatives
Collaborating closely with buyout companies
Developing a phase-based ESG enhancement approach for portfolio companies (e.g., JKP)

Frameworks Used: ILPA, SASB, HKEX ESG Reporting Guide, SFDR, IFC, UNPRI

Investing in industry-leading companies that contribute to promoting good health and well-being of humanity.

2023 Top 20 Best Healthcare Investors
Top 20 Most Popular Direct Investment Fund Institutions for Young Investors in 2024
2023 Top 30 Best Healthcare Institutional Investors
2023 Top 50 Best PE Funds, ranked 28th
2024 40 (40U40) Most Promising Young Investors in Direct Investment Funds under the Age of 40
2023 Top 20 Best Foreign PE Institutional Investors in China
2023 Top 20 Best Institutional Investors focusing on Medical Device in China's Medical and Healthcare Service Sector
2022-2023 Top 100 Best Private Equity Investors in China
Best Investment Return Fund of the Year in Healthcare
Best Investment Institution of the Year in Healthcare Services
Best PE Investment Institution of the Year in Healthcare